Horizon Therapeutics (HZNP) Tops Q2 EPS by 4c on Revenue Blowout, Raises Outlook
Go back to Horizon Therapeutics (HZNP) Tops Q2 EPS by 4c on Revenue Blowout, Raises OutlookHORIZON PHARMA (NASDAQ: HZNP) | Delayed: 116.30 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $116.30 | 52 Week High | $23.44 | |||
Open | $116.30 | 52 Week Low | $13.06 | |||
Day High | $116.30 | P/E | N/A | |||
Day Low | $116.30 | EPS | $-0.96 | |||
Volume | 1,264,098 |